iSpecimen Inc
NASDAQ:ISPC
iSpecimen Inc
NASDAQ:ISPC
Price:
0.1802
USD
-8.06%
Market Closed
Market Cap:
$1.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
iSpecimen Inc
NASDAQ:ISPC
|
US |
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
DK |
|
Anritsu Corp
TSE:6754
|
JP |
|
Atlantic Sapphire ASA
OTC:AASZF
|
NO |
|
Haimo Technologies Group Corp
SZSE:300084
|
CN |
|
G
|
Global Indemnity Group LLC
NYSE:GBLI
|
US |
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
CN |
|
Genertec Universal Medical Group Co Ltd
HKEX:2666
|
CN |
|
Ls Telcom AG
XETRA:LSX
|
DE |
|
T
|
Toyota Tsusho Corp
TSE:8015
|
JP |
|
S
|
Stille AB
STO:STIL
|
SE |
|
A&D Holon Holdings Co Ltd
TSE:7745
|
JP |
|
Anka India Ltd
BSE:531673
|
IN |
Income Statement
Earnings Waterfall
iSpecimen Inc
iSpecimen Inc
Income Statement
iSpecimen Inc
iSpecimen Inc
Currency: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
5
N/A
|
7
+30%
|
8
+21%
|
9
+15%
|
11
+15%
|
11
+4%
|
11
-1%
|
11
-4%
|
10
-5%
|
10
-1%
|
10
+4%
|
11
+4%
|
10
-7%
|
10
+2%
|
10
-4%
|
9
-7%
|
11
+13%
|
10
-1%
|
9
-11%
|
8
-13%
|
6
-27%
|
3
-43%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
|
| Gross Profit |
3
N/A
|
4
+38%
|
5
+12%
|
5
+6%
|
5
+8%
|
6
+9%
|
6
+3%
|
6
N/A
|
6
-1%
|
5
-7%
|
6
+4%
|
6
+8%
|
6
-9%
|
6
0%
|
5
-7%
|
5
-10%
|
5
+15%
|
5
-5%
|
4
-20%
|
3
-23%
|
2
-38%
|
1
-63%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(15)
|
(16)
|
(17)
|
(16)
|
(16)
|
(16)
|
(16)
|
(15)
|
(17)
|
(14)
|
(13)
|
(13)
|
|
| Selling, General & Administrative |
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(14)
|
(16)
|
(17)
|
(16)
|
(15)
|
(16)
|
(16)
|
(15)
|
(15)
|
(14)
|
(13)
|
(13)
|
|
| Research & Development |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(2)
+27%
|
(2)
-10%
|
(3)
-20%
|
(4)
-43%
|
(5)
-18%
|
(6)
-22%
|
(7)
-24%
|
(8)
-14%
|
(10)
-15%
|
(10)
-2%
|
(10)
-6%
|
(11)
-9%
|
(10)
+8%
|
(11)
-7%
|
(12)
-4%
|
(10)
+12%
|
(10)
+5%
|
(13)
-30%
|
(11)
+11%
|
(11)
+3%
|
(12)
-10%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
|
| Pre-Tax Income |
(5)
N/A
|
(4)
+17%
|
(5)
-4%
|
(7)
-50%
|
(8)
-18%
|
(8)
-4%
|
(9)
-6%
|
(7)
+18%
|
(9)
-17%
|
(10)
-18%
|
(10)
-1%
|
(10)
0%
|
(11)
-8%
|
(10)
+9%
|
(11)
-9%
|
(12)
-4%
|
(10)
+12%
|
(10)
+7%
|
(12)
-31%
|
(11)
+10%
|
(10)
+9%
|
(12)
-13%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(5)
|
(4)
|
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(7)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(11)
|
(12)
|
(10)
|
(10)
|
(12)
|
(11)
|
(10)
|
(12)
|
|
| Net Income (Common) |
(5)
N/A
|
(4)
+16%
|
(5)
-5%
|
(7)
-50%
|
(8)
-18%
|
(8)
-4%
|
(9)
-6%
|
(7)
+18%
|
(9)
-17%
|
(10)
-18%
|
(10)
-1%
|
(10)
0%
|
(11)
-8%
|
(10)
+9%
|
(11)
-9%
|
(12)
-4%
|
(10)
+12%
|
(10)
+7%
|
(12)
-31%
|
(11)
+10%
|
(10)
+9%
|
(12)
-13%
|
|
| EPS (Diluted) |
-0.81
N/A
|
-0.68
+16%
|
-0.72
-6%
|
-1.08
-50%
|
-1.26
-17%
|
-1.21
+4%
|
-1.03
+15%
|
-0.84
+18%
|
-0.97
-15%
|
-1.15
-19%
|
-1.16
-1%
|
-1.16
N/A
|
-1.25
-8%
|
-1.13
+10%
|
-24.55
-2 073%
|
-25.32
-3%
|
-17.97
+29%
|
-13.86
+23%
|
-17.58
-27%
|
-4.84
+72%
|
-4.08
+16%
|
-1.97
+52%
|
|
Switch to:
Switch to:
See Also
Discover More
